Entera Bio Schedule 13G Filed by Venrock Healthcare Capital Partners III
A Schedule 13G for Entera Bio was filed by Venrock Healthcare Capital Partners III, L.P.
Related stories
Microsoft Outlook Begins Returning After Global Microsoft 365 Disruption
Microsoft said it was working to restore email access after a global Microsoft 365 disruption. Industry executives warned of risks from dependence on a single technology provider.
M impact | EQUITY | Nov 14, 2026, 04:31 AM UTC
Tesla sells Cybercab to first private customers
Reuters reports Tesla is offering its Cybercab to its first private customers.
M impact | EQUITY | Nov 14, 2026, 04:23 AM UTC
Microsoft says affected services fully recovered
L impact | EQUITY | Nov 14, 2026, 04:14 AM UTC
Eicher Motors Q2 Net Profit Rises 15% but Misses Estimates
Second-quarter consolidated net profit rose 15% year on year to 1,573 crore, below analysts’ estimates. Rising raw-material costs offset gains from strong motorcycle sales.
M impact | EQUITY | Nov 14, 2026, 04:12 AM UTC
Warburg Pincus to Acquire 38% Stake in Pricol Unit for ₹1,663 Crore
Warburg Pincus will acquire the stake through affiliate Topaz Terrace Investments, according to a stock exchange disclosure.
M impact | EQUITY | Nov 14, 2026, 04:12 AM UTC
Southwest Resumes Limited Flights This Evening
Southwest Airlines says it is resuming a limited number of flights this evening after consulting with the FAA.
M impact | EQUITY | Nov 14, 2026, 04:02 AM UTC